null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-005109-30-FR

Enrollment

100

Registered

2015-06-16

Start date

2015-02-19

Completion date

Unknown

Last updated

2020-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 18.0 Level: PT Classification code 10008611 Term: Cholecystectomy System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: Ropivacaïne 7,5mg/ml Product Name: Ropivacaïne Pharmaceutical Form: Concentrate and solvent for solution for injection INN or Proposed INN:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 40

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactAUZANNEAU Lucie

Centre Hospitalier Départemental Vendée

lucie.auzanneau@chd-vendee.fr330251446380

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026